BIOMAT Database Logo BIOMAT Database Logo

Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model. 1981

K G Lurie, and M E Billingham, and S W Jamieson, and D C Harrison, and B A Reitz

Accelerated graft arteriosclerosis is a major cause of death in human heart transplantation. Despite many investigations, the pathogenesis of this disease remains undetermined and its control inadequate. In this study using a rat heart transplant model and cyclosporin A, a new immunosuppressant, acute rejection was prevented but arteriosclerotic-like vessel disease still developed consistently as early as 20 days postoperatively. The combination of cyclosporin A and dipyridamole prevented the development of this vessel disease in transplanted hearts at 20 and 50 days postoperatively. Sulfinpyrazone and cyclosporin A reduced but did not prevent the disease. These findings suggest that immunologically induced graft arteriosclerosis can be prevented in transplanted rat hearts by the combination of cyclosporin A and dipyridamole.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D013442 Sulfinpyrazone A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. Sulfoxyphenylpyrazolidin,Anturan,Anturane,Apo-Sulfinpyrazone,Nu-Sulfinpyrazone,Sulphinpyrazone,Apo Sulfinpyrazone,Nu Sulfinpyrazone

Related Publications

K G Lurie, and M E Billingham, and S W Jamieson, and D C Harrison, and B A Reitz
An experimental model of ischemia-produced transplant arteriosclerosis.
June 1998, Transplantation proceedings,
K G Lurie, and M E Billingham, and S W Jamieson, and D C Harrison, and B A Reitz
Control of graft arteriosclerosis in human heart transplant recipients.
March 1977, Surgery,
K G Lurie, and M E Billingham, and S W Jamieson, and D C Harrison, and B A Reitz
Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis.
February 1991, Transplantation proceedings,
K G Lurie, and M E Billingham, and S W Jamieson, and D C Harrison, and B A Reitz
Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration.
February 1995, Transplantation proceedings,
K G Lurie, and M E Billingham, and S W Jamieson, and D C Harrison, and B A Reitz
Cardiac transplant graft arteriosclerosis.
January 1991, Trends in cardiovascular medicine,
K G Lurie, and M E Billingham, and S W Jamieson, and D C Harrison, and B A Reitz
Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.
January 1991, Arteriosclerosis and thrombosis : a journal of vascular biology,
K G Lurie, and M E Billingham, and S W Jamieson, and D C Harrison, and B A Reitz
[Pathogenesis and prevention of arteriosclerosis].
January 1969, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
K G Lurie, and M E Billingham, and S W Jamieson, and D C Harrison, and B A Reitz
Heart graft arteriosclerosis.
March 1971, Transplantation proceedings,
K G Lurie, and M E Billingham, and S W Jamieson, and D C Harrison, and B A Reitz
Thalidomide attenuates graft arteriosclerosis of aortic transplant in a rat model.
June 2011, Transplantation proceedings,
K G Lurie, and M E Billingham, and S W Jamieson, and D C Harrison, and B A Reitz
Tadalafil attenuates graft arteriosclerosis of aortic transplant in a rat model.
September 2015, Iranian journal of basic medical sciences,
Copied contents to your clipboard!